Latest Options News

GTI Energy Ltd has announced a significant 40-for-1 consolidation of its securities, reshaping its capital structure with trading on the new basis set to begin in August 2025.

Bass Oil Limited reported a 4% rise in June oil production alongside advancing plans to acquire the Vanessa gas field, signaling a strategic pivot towards gas sales and resource expansion.

Askari Metals has acquired the Nejo Gold Project in Ethiopia, aiming to build a tier-1 gold portfolio in the underexplored Arabian-Nubian Shield. The company plans systematic exploration to unlock significant gold resources.

Bowen Coking Coal has started owner-operated mining at its Burton Mine Complex with a reduced fleet and production focus, responding to weak global steel markets and low coal prices. The company is actively pursuing refinancing and strategic funding to sustain operations during this challenging period.

Tambourah Metals has successfully completed an oversubscribed entitlement offer, raising $367,720 to fund drilling and exploration across its gold and critical minerals projects in Western Australia.

GBM Resources has received the initial $400,000 payment from Lithium Energy as part of a staged $3.2 million sale of its Mt Morgan Gold-Copper Project, marking a key step in its strategic asset divestment.

Kinterra Capital has increased its takeover offer for New World Resources Limited to A$0.064 per share and extended the acceptance deadline to July 17, signaling renewed confidence in securing control.

DY6 Metals has raised A$4.625 million through a placement to accelerate exploration of its rutile projects in Cameroon, alongside appointing industry veteran Cliff Fitzhenry as CEO to lead the charge.

Buru Energy has taken a major step forward in developing its Rafael Gas Project through a strategic partnership with Clean Energy Fuels Australia, aiming for first cash flow by late 2027. The company also divested non-core assets to focus capital on this flagship project.

Imugene Limited reports promising Phase 1b trial results for azer-cel, an off-the-shelf CAR T therapy, showing a 75% overall response rate in relapsed diffuse large B-cell lymphoma patients. The company plans to engage the FDA later this year to discuss pivotal trial design.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Macquarie Technology Group’s subsidiary has secured an option to acquire a prime Sydney site for a major new data centre campus, aiming to boost capacity for AI, cloud, and government clients.